The Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction in Rural Malawian Children 1-3 Year Olds

Sponsor
Washington University School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT02472301
Collaborator
(none)
337
1
3
16
21

Study Details

Study Description

Brief Summary

To determine if 12 months of legume-based complementary foods is effective in reducing or reversing EED and linear growth faltering in a cohort of Malawian children, aged 12-35 months to see if these improvements are correlated with specific changes in the enteric microbiome.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: cowpeas complementary food
  • Dietary Supplement: corn-soy flour
  • Dietary Supplement: common bean complementary food
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
337 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Randomized, Single-blinded, Prospective Clinical Trial Comparing the Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction and Stunting in Rural Malawian Children 1-3 Year Olds
Actual Study Start Date :
Aug 1, 2015
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cowpeas

Cowpea supplementary food that will be approximately 15% of the calculated total daily intake. Children will receive the food for 12 months.

Dietary Supplement: cowpeas complementary food
cowpeas supplementary food that will be approximately 15% of the calculated total daily intake. Children will receive the food for 12 months.

Experimental: Common bean

Common bean supplementary food that will be approximately 15% of the calculated total daily intake. Children will receive the food for 12 months.

Dietary Supplement: common bean complementary food
common bean supplementary food that will be approximately 15% of the calculated total daily intake. Children will receive the food for 12 months.

Active Comparator: Corn Soy Flour

Corn flour with 10% soy supplementary food that will be approximately 15% of the calculated total daily intake. Children will receive the food for 12 months.

Dietary Supplement: corn-soy flour
Corn-soy flour supplementary food that will be approximately 15% of the calculated total daily intake. Children will receive the food for 12 months.

Outcome Measures

Primary Outcome Measures

  1. Dual Sugar Absorption Test [3 months]

    lactulose-mannitol ratio in urine

  2. Dual Sugar Absorption Test [6 months]

    lactulose-mannitol ratio in urine

  3. Dual Sugar Absorption Test [12 months]

    lactulose-mannitol ratio in urine

Secondary Outcome Measures

  1. Lactulose Excretion [3 months]

    percentage of ingested lactulose excreted in urine

  2. Lactulose Excretion [6 months]

    percentage of ingested lactulose excreted in urine

  3. Lactulose Excretion [12 months]

    percentage of ingested lactulose excreted in urine

  4. Mannitol Excretion [3 months]

    percentage of ingested mannitol excreted in urine

  5. Mannitol Excretion [6 months]

    percentage of ingested mannitol excreted in urine

  6. Mannitol Excretion [12 months]

    percentage of ingested mannitol excreted in urine

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Months to 35 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • children residing in catchment area of Limela, Machinga District and N tenda (Chikwawa District), Malawi

  • aged 12-35 months

  • youngest eligible child in each household

Exclusion Criteria:Unable to drink 20 mL of sugar water

  • Demonstrating evidence of severe acute malnutrition, WHZ < or = -3, presence of bi-pedal pitting edema

  • Apparent need for acute medical treatment for an illness or injury

  • Caregiver refusal to participate and return for 3, 6 and 12 month follow-ups

Contacts and Locations

Locations

Site City State Country Postal Code
1 Blantyre Malawi

Sponsors and Collaborators

  • Washington University School of Medicine

Investigators

  • Principal Investigator: Mark Manary, MD, Washington University School of Medince

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT02472301
Other Study ID Numbers:
  • LG2
First Posted:
Jun 15, 2015
Last Update Posted:
May 11, 2017
Last Verified:
May 1, 2017
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 11, 2017